Dr. Elizabeth Konadu, MD

Dr. Konadu practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Konadu's NPI, 1629278692, was assigned on July 19, 2007. Dr. Konadu graduated from University of Massachusetts Medical School in 2013. Dr. Konadu holds Massachusetts license 233430.

Dr. Konadu's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Konadu's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Konadu is also affiliated with Carroll Hospital. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Konadu practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Konadu's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Konadu is licensed in Massachusetts.

CMS data shows 1,466 Medicare services from Dr. Konadu across 11 procedure codes in 2024, for 710 Medicare patients. Medicare paid $93,504 for them.

CMS counts 710 Medicare patients who saw Dr. Konadu in 2024. The largest group is 65 to 74, with 275 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Konadu's median patient age at 66, with 46% women.

In 2024, Dr. Konadu wrote 2,722 Medicare Part D claims for 535 patients. 83% of them were for generic drugs. CMS names the drug for 2,517 of them, across 36 drugs with 11 or more claims each, at $568,076 in total drug cost. In 2023, CMS named 3,410 claims across 43 drugs.

Dr. Konadu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Konadu in 2015. Dr. Konadu's most frequent co-authors are Robert Goldberg, MD, Samuel Joffe, MD and Michael Kiernan, MD.

CMS Open Payments shows 349 general payments to Dr. Konadu from 29 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $671.

Dr. Konadu graduated from University of Massachusetts Medical School in 2013.